Usefulness of consecutive biomarkers measurement in the management of community-acquired pneumonia

No abstract is available for this paper.

• Publication year

  2012

• Venue

  European Journal of Clinical Microbiology and Infectious Diseases

• Publication date

  2012-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s10096-011-1381-0PMID 21870054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MR-pro-atrial natriuretic peptide (MR-proANP) predicts short- and long-term outcomes in respiratory tract infections: a prospective validation study.

  2012cited by this paper
• Ahlstrand E , Persson L , Tidefelt U , Söderquist B. Alteration of the colonization pattern of coagulase-negative staphylococci in patients undergoing treatment for hematological malignancy. Eur J Clin Microbiol Infect Dis

  2011cited by this paper
• Usefulness of mid regional pro-atrial natriuretic peptide in the exacerbations of chronic obstructive pulmonary disease.

  2011cited by this paper
• Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: Derivation of a clinical algorithm

  2011cited by this paper
• Long-term stability of procalcitonin in frozen samples and comparison of Kryptor and VIDAS automated immunoassays.

  2010cited by this paper
• Cardiovascular and inflammatory biomarkers to predict short- and long-term survival in community-acquired pneumonia: Results from the German Competence Network, CAPNETZ.

  2010cited by this paper
• Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post-study survey

  2010cited by this paper
• Pro-atrial natriuretic peptide and pro-vasopressin for predicting short-term and long-term survival in community-acquired pneumonia: results from the German Competence Network CAPNETZ

  2010cited by this paper
• Prognostic value of procalcitonin in community-acquired pneumonia

  2010cited by this paper
• Utility of pneumococcal urinary antigen detection in diagnosing exacerbations in COPD patients.

  2010cited by this paper
• Accuracy of C-reactive protein, procalcitonin, and mid-regional pro-atrial natriuretic peptide to guide site of care of community-acquired pneumonia

  2010cited by this paper
• Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia.

  2009cited by this paper
• Markers of treatment failure in hospitalised community acquired pneumonia

  2009cited by this paper
• Biomarkers in the management of COPD

  2009cited by this paper
• Persistence of Streptococcus pneumoniae urinary antigen excretion after pneumococcal pneumonia

  2009cited by this paper
• Effect of Procalcitonin-Guided Treatment in Patients with Infections: a Systematic Review and Meta-Analysis

  2009cited by this paper
• Stability in community-acquired pneumonia: one step forward with markers?

  2009cited by this paper
• Biomarkers improve mortality prediction by prognostic scales in community-acquired pneumonia

  2009cited by this paper
• Procalcitonin kinetics in Legionella pneumophila pneumonia.

  2009cited by this paper
• Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia.

  2009cited by this paper
• Diagnostic utility of CRP to neopterin ratio in patients with acute respiratory tract infections.

  2009cited by this paper
• Markers of treatment failure in hospitalised community acquired pneumonia

  2008cited by this paper
• Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia

  2008cited by this paper
• Procalcitonin predicts patients at low risk of death from community-acquired pneumonia across all CRB-65 classes

  2008cited by this paper
• Midregional pro-A-type natriuretic peptide and carboxy-terminal provasopressin may predict prognosis in community-acquired pneumonia.

  2007cited by this paper
• Midregional pro-atrial natriuretic peptide as a prognostic marker in pneumonia.

  2007cited by this paper
• Biomarkers in respiratory tract infections: diagnostic guides to antibiotic prescription, prognostic markers and mediators

  2007cited by this paper
• Value of serum procalcitonin, neopterin, and C-reactive protein in differentiating bacterial from viral etiologies in patients presenting with lower respiratory tract infections.

  2007cited by this paper
• Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

  2007cited by this paper
• Biomarkers to improve diagnostic and prognostic accuracy in systemic infections

  2007cited by this paper
• Procalcitonin and neopterin correlation with aetiology and severity of pneumonia.

  2006influential reference
• Impact of rapid urine antigen tests to determine the etiology of community-acquired pneumonia in adults.

  2006cited by this paper
• Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia

  2006cited by this paper
• Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial.

  2006cited by this paper
• Circulating levels of pro‐atrial natriuretic peptide in lower respiratory tract infections

  2006cited by this paper
• Markers of acute inflammation in assessing and managing lower respiratory tract infections: focus on procalcitonin

  2006cited by this paper
• Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index.

  2005cited by this paper
• C-reactive Protein*

  2004cited by this paper
• Serum procalcitonin and C-reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis.

  2004cited by this paper
• Contribution of C-reactive protein to the diagnosis and assessment of severity of community-acquired pneumonia.

  2004cited by this paper
• Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection

  2003cited by this paper
• C-reactive protein levels in community-acquired pneumonia

  2003cited by this paper
• Usefulness of Urinary Antigen Detection by an Immunochromatographic Test for Diagnosis of Pneumococcal Pneumonia in Children

  2003cited by this paper
• Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

  2003cited by this paper
• The influence of the severity of community-acquired pneumonia on the usefulness of blood cultures.

  2001cited by this paper
• Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples.

  2001cited by this paper
• Assessment of a new test to detect Legionella urinary antigen for the diagnosis of Legionnaires' Disease.

  2001cited by this paper
• Procalcitonin and C-Reactive Protein Levels in Community-Acquired Pneumonia: Correlation with Etiology and Prognosis

  2000cited by this paper
• A prediction rule to identify low-risk patients with community-acquired pneumonia.

  1997cited by this paper
• Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community-acquired pneumonia.

  1995cited by this paper
• Clinical Investigations: InfectionC-Reactive Protein: A Clinical Marker in Community-Acquired Pneumonia

  1995cited by this paper
• Infectious Diseases Society of America

  1969cited by this paper
• International Journal of Copd Dovepress Value of Procalcitonin, C-reactive Protein, and Neopterin in Exacerbations of Chronic Obstructive Pulmonary Disease

  year unknowncited by this paper

• Effects of lymphocyte and neutrophil counts and their time courses on mortality in patients with postoperative pneumonia

  2022cites this paper
• Kinetics of inflammatory biomarkers to predict one-year mortality in elderly patients hospitalized for pneumonia: a multivariable analysis.

  2022cites this paper
• Role of Clinical Characteristics and Biomarkers at Admission to Predict One-Year Mortality in Elderly Patients with Pneumonia

  2021influential citation
• Respiratory Tract Infections: Bacteria

  2021cites this paper
• Polmonite acuta comunitaria dell’adulto al Pronto Soccorso

  2020cites this paper
• Procalcitonin and C-reactive protein perform better than the neutrophil/lymphocyte count ratio in evaluating hospital acquired pneumonia

  2020cites this paper
• Procalcitonin and C-reactive Protein Perform Better Than Neutrophil-Lymphocyte Count Ratio on Evaluation of Hospital Acquired Pneumonia

  2020cites this paper
• Biomarkers and Disease Severity in Children With Community-Acquired Pneumonia

  2020cites this paper
• Bloodstream Bacterial Infection in Neutropenic Acute Leukemia Patients

  2020cites this paper
• Independent Prognostic Indicators in the Elderly with Pneumonia: A Single-Center Prospective Observational Study

  2019cites this paper
• [Immunocompetent adults hospitalized for a community-acquired pneumonia: Serum C-reactive protein as a prognostic marker].

  2019cites this paper
• Pneumonie aiguë communautaire de l’adulte aux urgences

  2019cites this paper
• Procalcitonin is not an independent predictor of 30-day mortality, albeit predicts pneumonia severity in patients with pneumonia acquired outside the hospital

  2019cites this paper
• Early prediction of treatment failure in severe community-acquired pneumonia: The PRoFeSs score.

  2019cites this paper
• Combined use of the multidimensional prognostic index (MPI) and procalcitonin serum levels in predicting 1-month mortality risk in older patients hospitalized with community-acquired pneumonia (CAP): a prospective study

  2018cites this paper
• Guideline for Antibiotic Use in Adults with Community-acquired Pneumonia

  2018cites this paper
• Host-response biomarkers for the diagnosis of bacterial respiratory tract infections

  2018cites this paper
• Utility of Procalcitonin in the Management of Hospital-Acquired Pneumonia - A Review

  2018cites this paper
• Procalcitonin kinetics in the first 48 hours of ICU admission is associated with higher mortality in critically ill patients with community-acquired pneumonia in a setting of high HIV prevalence

  2018cites this paper
• Utility of procalcitonin in predicting mortality among cases of hospital-acquired pneumonia: a North Indian study

  2018cites this paper
• Usefulness and prognostic value of biomarkers in patients with community-acquired pneumonia in the emergency department.

  2017cites this paper
• Serial Procalcitonin as a Predictor of Bacteremia and Need for Intensive Care Unit Care in Adults With Pneumonia, Including Those With Highest Severity: A Prospective Cohort Study

  2017cites this paper
• Tools for outcome prediction in patients with community acquired pneumonia

  2017cites this paper
• Utilidad y valor pronóstico de los biomarcadores en los pacientes con neumonía adquirida en la comunidad en los servicios de urgencias

  2017cites this paper
• mproved Management of Community-Acquired Pneumonia in the mergency Department

  2017cites this paper
• Macrolides: Are They Safe Bet in Management of Community Acquired Pneumonia (CAP) in Elderly Patients Admitted to an Intensive Care Unit (ICU)

  2017cites this paper
• Postobstructive Pneumonia: An Underdescribed Syndrome

  2016influential citation
• Serum procalcitonin and C-reactive protein kinetics as indicators of treatmentoutcome in hospitalized patients with community-acquired pneumonia.

  2016cites this paper
• Prognostic value of procalcitonin in pneumonia: A systematic review and meta‐analysis

  2015cites this paper
• Biomarkers in differentiating clinical dengue cases: A prospective cohort study

  2015cites this paper
• Внебольничная пневмония у пациентов пожилого и старческого возраста

  2015cites this paper
• Capacidad de la procalcitonina para predecir bacteriemia en pacientes con neumonía adquirida en la comunidad

  2014cites this paper
• A Pilot Study on the Diagnostic Accuracy of Proadrenomedullin and Proatrial Natriuretic Peptide in Lower Respiratory Tract Infections

  2014cites this paper
• Procalcitonin levels in community-acquired pneumonia – correlation with aetiology and severity

  2014cites this paper
• [Usefulness of inflammation and infection biomarkers in the Emergency Department].

  2014cites this paper
• [Ability of procalcitonin to predict bacteremia in patients with community acquired pneumonia].

  2014cites this paper
• [Diagnostic and prognostic power of biomarkers to improve the management of community acquired pneumonia in the emergency department].

  2014cites this paper
• Improved Management of Community-Acquired Pneumonia in the Emergency Department

  2013cites this paper
• Improved management of community-acquired pneumonia in the emergency department.

  2013cites this paper
• Community-acquired pneumonia

  2013cites this paper
• Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?

  2013cites this paper
• Diagnosis of Pneumococcal Pneumonia: Current Pitfalls and the Way Forward

  2013cites this paper
• Biomarkers: what is their benefit in the identification of infection, severity assessment, and management of community-acquired pneumonia?

  2013cites this paper
• Community-acquired pneumonia

  2013cites this paper
• Diagnostics for community-acquired and atypical pneumonia.

  2012cites this paper
• Biomarqueurs et pneumonie aiguë communautaire

  2012cites this paper
• Les biomarqueurs en médecine d’urgence

  2012cites this paper
• Aetiology in community-acquired pneumonia

  2012cites this paper
• Biomarkers in community-acquired pneumonia

  2012cites this paper
• Serial and panel analyses of biomarkers do not improve the prediction of bacteremia compared to one procalcitonin measurement.

  2012cites this paper